# Supreet Deshpande

> Supreet Deshpande is Co-Founder and CEO of Synthio Labs, a Y Combinator-backed startup building clinical-grade voice AI for the life sciences industry. Drawing on his experience leading Gen AI for Life Sciences at McKinsey and analytics work at ZS Associates and JPMorgan Chase, Deshpande is solving a stubborn pharma problem: 70% of physicians never hear from a field team despite billions spent. Synthio's AI voice agents - reaching every clinician and patient with compliant, multilingual, FDA-aligned conversations - raised a $5M seed round led by Elevation Capital in November 2025 and already counts several Top 10 pharma companies as customers.

- **Role:** Co-Founder and CEO at Synthio Labs
- **Organizations:** Synthio Labs, Y Combinator, McKinsey & Company, ZS Associates, JPMorgan Chase & Co., Winkl, North Carolina State University
- **Nationality:** Indian-American
- **Education:** M.S. in Advanced Analytics, Data Science, North Carolina State University (NCSU)
- **Known for:** Co-founded Synthio Labs, selected for Y Combinator Spring 2025, Raised $5M seed round from Elevation Capital, Peak XV Partners, and 1984 Ventures (November 2025), Named to Forbes' 'Most Promising Startups From the First-Ever YC Spring Batch' (June 2025)

## Career timeline

- **2010** — Joined Twitter/X (@iamsupreetd), indicating early tech engagement
- **2018-2019** — Pursued M.S. in Advanced Analytics at NCSU; won 1st place 'Best Insight' at the 2019 Carolina Data Challenge for time series analysis of U.S. sorghum farmers impacted by the agricultural trade war
- **Pre-2020** — Data analyst role at JPMorgan Chase & Co.
- **Pre-2020** — Analytics work at ZS Associates on pharma promotion response, portfolio sizing, and sales force optimization
- **Pre-2020** — Role at Winkl
- **2020-2023** — Senior role at McKinsey & Company leading 'Gen AI for Life Sciences' initiatives across top 50 pharma companies and biotechs in clinical development, medical affairs, and commercial operations
- **2024** — Co-founded Synthio Labs with Sahitya Sridhar (CPO, ex-Audible/Amazon) and Rajashekar Vasantha (CTO, ex-AWS)
- **2025** — Accepted into Y Combinator Spring 2025 batch; named to Forbes' 'Most Promising Startups From the First-Ever YC Spring Batch'
- **2025-11** — Raised $5M seed round led by Elevation Capital with participation from 1984 Ventures, Peak XV Partners, and Y Combinator

## Achievements

- Co-founded Synthio Labs, selected for Y Combinator Spring 2025
- Raised $5M seed round from Elevation Capital, Peak XV Partners, and 1984 Ventures (November 2025)
- Named to Forbes' 'Most Promising Startups From the First-Ever YC Spring Batch' (June 2025)
- Won 1st place for 'Best Insight' at the 2019 Carolina Data Challenge (NCSU)
- Led Gen AI for Life Sciences at McKinsey, working with top 50 pharma companies globally
- Deployed voice AI delivering 5,000 patient calls in 48 hours for a D2C healthcare brand
- Secured early customers among Top 10 global pharma companies

## Latest updates

- **2025-11** — Synthio Labs raised $5M seed round led by Elevation Capital to expand engineering teams in the U.S. and India and scale enterprise deployments in North America and Europe
- **2025-06** — Forbes named Synthio Labs one of the most promising startups from the first-ever Y Combinator Spring batch
- **2025-03** — Synthio Labs accepted into Y Combinator Spring 2025 batch

## Links

- Website: https://synthiolabs.com
- LinkedIn: https://www.linkedin.com/in/supreetdeshpande/
- Twitter/X: https://x.com/iamsupreetd
- GitHub: https://github.com/supreet95

---

Profile page: https://yespress.io/supreet-deshpande
Published by YesPress — https://yespress.io
Last updated: 2026-05-13